NCT06582589 - HEALSea Nasal Spray for Prevention of Infections in Children | Biotech Hunter

Enrollment

139

Participants

Timeline

Start Date

November 25, 2024

Primary Completion Date

April 23, 2025

Study Completion Date

April 23, 2025

Conditions

Healthy Subjects

Interventions

DEVICE

Healsea Children

Subjects will use Healsea Children 1 puff in each nostril twice daily upon awakening and at bedtime, during three 28-day treatment periods interspersed by a 10-day wash-out

Trial Locations (8)

1000

Medical Center Iskar EOOD, Sofia

1303

Medical Center Polymed AD, Sofia

1404

Medical Center First Pediatric, Sofia

1618

Multiprofile Hospital for active treatment, Sofia

1680

Diagnostics and Consultation Center Convex EOOD, Sofia

2600

Multiprofile Hospital for Active Treatment Sveti Ivan Rilski -2003 OOD, Dupnitsa

3001

Ambulatory for individual Practice for specialized outpatient medical care for children's diseases and pediatric pneumology ans phtysiatry, Vratsa

4023

Medical Center Plovdimed Ltd, Plovdiv